U.S. Ai-Based Clinical Trials Solution Provider Market

Name: U.S. Ai-Based Clinical Trials Solution Provider Market
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The ai-based clinical trials solution provider market in the United States is expected to reach a projected revenue of US$ 2,165.5 million by 2030. A compound annual growth rate of 17.9% is expected of the United States ai-based clinical trials solution provider market from 2022 to 2030.

U.S. artificial intelligence based clinical trials solution provider therapeutic applications outlook (Revenue, USD million, 2018-2030)
- Oncology
- CVD
- Neurological Diseases or conditions
- Metabolic diseases
- Infectious diseases
- Others
U.S. artificial intelligence based clinical trials solution provider clinical trial phase outlook (Revenue, USD million, 2018-2030)
- Phase-I
- Phase-II
- Phase-III
U.S. artificial intelligence based clinical trials solution provider end user outlook (Revenue, USD million, 2018-2030)
- Pharmaceutical Companies
- Academia
- Others

U.S. Ai-Based Clinical Trials Solution Provider Market

Sign up - it's easy, and free!